Sources | Names Used |
---|---|
CTRPv2 | JQ-1:MK-0752 (1:1 mol/mol) |
PharmacoGx | JQ-1:MK-0752 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | VANGL2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | TET3 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | TNS3 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | NFAT5 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | ANP32E | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | MORC2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | SLC16A13 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | LMBRD2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | COL25A1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | ADAMTSL5 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |